Michael D Jensen MD

Diabetes, Lipid Metabolism, Obesity

Professor, Internal Medicine, Mayo Medical School

200 1st St SWRochester, MN 55905
Phone+1 507-284-2511

Dr. Jensen is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Jensen's full profile Already have an account?

Education & Training

Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Endocrinology, Diabetes, and Metabolism, 1982 - 1985
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1980 - 1982
St Luke's HospitalInternship, Internal Medicine, 1979 - 1980
University of Missouri Kansas City School of MedicineClass of 1979
University of Missouri-Kansas CityBA, Biology, 1977

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

MN State Medical License 1981 - 2027
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification Centricity Enterprise (CE), GE Healthcare, 2014-2016
CMS Meaningful Use Stage 2 Certification Centricity Patient Online, GE Healthcare, 2014-2016
CMS Meaningful Use Stage 1 Certification Centricity Patient Online, GE Healthcare, 2014-2016

Clinical Trials

Influence of Male Hormones on Regional Fat Metabolism
COMPLETED
PHASE1
Long-term, Substantial Weight Loss and Insulin Regulation of Lipolysis Start of enrollment: 2019 Aug 01
RECRUITING
NA

Publications & Presentations

PubMed

Clinical Implications of Resting Metabolic Rate in Heart Failure with Preserved Ejection Fraction.
Tatsuro Ibe, Jwan A Naser, Tomonari Harada, Atsushi Tada, Shunichi Doi
Journal of Cardiac Failure. 2026-07-27
Stopping Spin at the Source: Learning From an Example in Obesity.
Andrew W Brown, Michael Jensen, David B Allison
Obesity. 2026-06-01
Effects of Sex and Obesity on Lipid Metabolism during Low-Intensity Exercise and Postexercise Period.
Damla N Costa, Michael D Jensen
Medicine and Science in Sports and Exercise. 2026-05-01

Journal Articles

Adiposity Genetic Risk Score Modifies the Association Between Blood Lead Level and Body Mass Index
Michael Jensen, MD, The Journal of Clinical Endocrinology and Metabolism
Proinflammatory cytokines differentially regulate adipocyte mitochondrial metabolism, oxidative stress, and dynamics
Hahn WS, Kuzmicic J, Burrill JS, Donoghue MA, Foncea R, Jensen MD, Lavandero S, Arriaga EA, Bernlohr DA, Am J Physiol Endocrinol Metab., 1/1/2014
Clinical effects of high-fat meals and weight gain due to high-fat feeding
Gupta N, Jensen MD, Int J Obes., 12/1/2012

Books/Book Chapters

Goldman's Cecil Medicine
Chapter: Obesity.
Page 1409 - 1417Jensen MDEditors: Goldman L; Schafer AI.Elsevier/Saunders, PhiladelphiaEdition 24th,2012
Clinical dilemmas in diabetes
Chapter: Primary therapy for obesity as the treatment of type 2 diabetes.
Page 107 - 115Mundi MS, Jensen MDEditors: Vella A; Rizza RA.Wiley-Blackwell, Chichester, Hoboken2011
Abdominal obesity and the endocannabinoid system: from basic aspects to clinical management of related cardiometabolic risk
Chapter: Free fatty acid metabolism in visceral obesity
Ali A, Jensen MD2009

Abstracts/Posters

Detailed Multi-Method Analysis of Bone Marrow from Pediatric Pre-B-ALL Patients Prior to CD19-CAR-T Therapy Subsequently Evidencing Overt CAR-T Resistance
Michael C. Jensen, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Clinical Experience of CAR T Cell Immunotherapy for Relapsed and Refractory Infant ALL Demonstrates Feasibility and Favorable Responses
Michael C. Jensen, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Additional Cytotoxic Chemotherapy Is Unlikely to Eliminate Measurable Residual Acute Myeloid Leukemia (AML)
Michael C. Jensen, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

Novel Treatment Targets for Obesity
Mumbai, India - 1/1/2012
Approach to weight loss: Mayo Clinic style and tactics
Mumbai, India - 1/1/2012
Metabolic Obesity in Non-Obese Adults
San Francisco, CA - 11/1/2011

Press Mentions

Mayo Clinic Research in the News — 4/12/2021April 12th, 2021
The Obesity Society 2019 Awards and GrantsDecember 20th, 2019
Good Advice on Obesity? Wait for It…December 7th, 2019

Grant Support

Regional Fatty Acid Metabolism In HumansMAYO CLINIC ROCHESTER1992–2030
Regional Fatty Acid Metabolism In HumansMAYO CLINIC ROCHESTER1992–2030
Diabetes and MetabolismMAYO CLINIC ROCHESTER1979–2029
FFA Metabolism in Different Types of Human ObesityMAYO CLINIC ROCHESTER1988–2028
Metabolic Studies CoreNational Institute Of Diabetes And Digestive And Kidney Diseases2006–2012